College of Science

A new alliance to accelerate biomarker validation and forge new breakthroughs in early disease detection has been launched by scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine and Massachusetts-based Thermo Fisher Scientific Inc.’s Biomarker Research Initiatives in Mass Spectrometry Center, or BRIMS Center.

A new study by researchers at George Mason University suggests that companies which participate in voluntary environmental programs do worse in their attempts to help the environment than those that do not take on these programs.

If you are a high school or college student interested in exploring the cutting edge of science and medicine, gaining hands-on experience with state-of-the-art technologies in a university research laboratory, and mentoring with high-profile scientists, apply now for the 2008 Aspiring Scientists Summer Internship Program at George Mason University.

Scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine have invented an innovative nanotechnology tool that may lead to a dramatic improvement in treatment results for patients diagnosed with cancer or other diseases.

Scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine and clinicians at the Inova Fairfax Hospital Cancer Center are partnering to take a revolutionary step forward in breast cancer research that could lead to new strategies for breast cancer screening, intervention to prevent breast cancer at the pre-invasive stage and treatment of advanced metastatic disease, and significantly alter how oncologists treat breast cancer.

The planning and design of the George Mason University Biomedical Research Lab (BRL) is progressing smoothly and construction should begin in early 2008. The BRL will contain Biosafety Level 3 (BSL-3) laboratories where Mason researchers will develop and test the next generation of vaccines, treatments and diagnostics to protect citizens against biological terrorism and infectious diseases.

Researchers at George Mason University’s National Center for Biodefense and Infectious Diseases and its Center for Applied Proteomics and Molecular Medicine are merging their expertise in host-pathogen biology, proteomics and nanotechnology to discover tissue and bloodborne markers that could be used for the early detection of exposure to infectious diseases.

George Mason University proteomics researchers Lance Liotta, MD, PhD, and Emanuel Petricoin, PhD, today announced the formation of a new company—Theranostics Health, LLC—that will use their breakthrough technology to provide critical new services to medical professionals on the front line of the war on cancer.

George Mason University climate scientist Jagadish Shukla says that the Intergovernmental Panel on Climate Change’s (IPCC) prediction of increased global warming is not extreme enough.

Abul Hussam, associate professor of chemistry and biochemistry, received the 2007 Grainger Challenge Prize for Sustainability Gold Award of $1 million yesterday from the National Academy of Engineering. The award recognized his innovative solution for removing arsenic from drinking water that is poisoning tens of millions of people in developing countries.